387 related articles for article (PubMed ID: 19788455)
21. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
[TBL] [Abstract][Full Text] [Related]
22. Bilirubin adsorption properties of water-soluble adsorbents with different cyclodextrin cavities in plasma dialysis system.
Wang Z; Cao Y; Wei H; Jia L; Xu L; Xie J
Colloids Surf B Biointerfaces; 2012 Feb; 90():248-53. PubMed ID: 22037476
[TBL] [Abstract][Full Text] [Related]
23. Single Pass Albumin Dialysis-A Dose-Finding Study to Define Optimal Albumin Concentration and Dialysate Flow.
Schmuck RB; Nawrot GH; Fikatas P; Reutzel-Selke A; Pratschke J; Sauer IM
Artif Organs; 2017 Feb; 41(2):153-161. PubMed ID: 27121702
[TBL] [Abstract][Full Text] [Related]
24. Albumin dialysis in critically ill patients: use versus omission of intradialytic heparin.
Yang WS; Tan HK; Lui HF; Chow PK; Choong HL; Wong KS
Artif Organs; 2008 May; 32(5):411-6. PubMed ID: 18471171
[TBL] [Abstract][Full Text] [Related]
25. Hypoglycemia in nondiabetic patients undergoing albumin dialysis by molecular adsorbent recirculating system.
Khoo AL; Tham LS; Lim GK; Lee KH
Liver Transpl; 2003 Sep; 9(9):949-53. PubMed ID: 12942456
[TBL] [Abstract][Full Text] [Related]
26. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis.
Churchwell MD; Pasko DA; Smoyer WE; Mueller BA
Nephrol Dial Transplant; 2009 Jan; 24(1):231-8. PubMed ID: 18723569
[TBL] [Abstract][Full Text] [Related]
27. Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial.
Wallon G; Guth C; Guichon C; Thevenon S; Gazon M; Viale JP; Schoeffler M; Duperret S; Aubrun F
Blood Purif; 2022; 51(3):243-250. PubMed ID: 34139706
[TBL] [Abstract][Full Text] [Related]
28. [The clinical experience with MARS and Prometheus procedures].
Hydzik P; Gawlikowski T; Ciszowski K; Sułlek M
Przegl Lek; 2007; 64(4-5):352-4. PubMed ID: 17724911
[TBL] [Abstract][Full Text] [Related]
29. Albumin dialysis without anticoagulation in high-risk patients: an observational study.
Tan HK; Yang WS; Choong HL; Wong KS
Artif Organs; 2012 Mar; 36(3):E83-8. PubMed ID: 21091517
[TBL] [Abstract][Full Text] [Related]
30. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation.
Krisper P; Haditsch B; Stauber R; Jung A; Stadlbauer V; Trauner M; Holzer H; Schneditz D
J Hepatol; 2005 Sep; 43(3):451-7. PubMed ID: 16023249
[TBL] [Abstract][Full Text] [Related]
31. Clearing of toxic substances: are there differences between the available liver support devices?
Krisper P; Stadlbauer V; Stauber RE
Liver Int; 2011 Sep; 31 Suppl 3():5-8. PubMed ID: 21824275
[TBL] [Abstract][Full Text] [Related]
32. Clamping of the dialysate outlet line in the Genius dialysis system does not alter dialysate flow or clearances.
Van Biesen W; Eloot S; Verleysen A; Glorieux G; Veys N; Vanholder R; Lameire N
Nephrol Dial Transplant; 2006 Apr; 21(4):1069-72. PubMed ID: 16410271
[TBL] [Abstract][Full Text] [Related]
33. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure.
Oettl K; Stadlbauer V; Krisper P; Stauber RE
Ther Apher Dial; 2009 Oct; 13(5):431-6. PubMed ID: 19788461
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of serum protein binding of felodipine.
Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
[TBL] [Abstract][Full Text] [Related]
35. Stability of therapeutic albumin solutions used for molecular adsorbent recirculating system-based liver dialysis.
De Bruyn T; Meijers B; Evenepoel P; Laub R; Willems L; Augustijns P; Annaert P
Artif Organs; 2012 Jan; 36(1):29-41. PubMed ID: 21955219
[TBL] [Abstract][Full Text] [Related]
36. Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies.
Mariano F; Fonsato V; Lanfranco G; Pohlmeier R; Ronco C; Triolo G; Camussi G; Tetta C; Passlick-Deetjen J
Nephrol Dial Transplant; 2005 Jun; 20(6):1116-26. PubMed ID: 15814541
[TBL] [Abstract][Full Text] [Related]
37. Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure.
Evenepoel P; Laleman W; Wilmer A; Claes K; Maes B; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
Blood Purif; 2005; 23(5):349-58. PubMed ID: 16020951
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal albumin dialysis.
Abe T; Shono M; Kodama T; Kita Y; Fukagawa M; Akizawa T
Ther Apher Dial; 2004 Jun; 8(3):217-22. PubMed ID: 15154874
[TBL] [Abstract][Full Text] [Related]
39. A new procedure for the removal of protein bound drugs and toxins.
Stange J; Mitzner S; Ramlow W; Gliesche T; Hickstein H; Schmidt R
ASAIO J; 1993; 39(3):M621-5. PubMed ID: 8268613
[TBL] [Abstract][Full Text] [Related]
40. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
